Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis

Affiliations

Vincenzo C. Leo: Pfizer Ltd, Walton Oaks Dorking Rd Tadworth KT20 7NS UK
Syed Kazmi: Hull University Teaching Hospitals Trust, Castle Hill Hospital Castle Rd Cottingham HU16 5JQ UK
Jack Brownrigg: Pfizer Ltd, Walton Oaks Dorking Rd Tadworth KT20 7NS UK
Marzieh Araghi: Pfizer Ltd, Walton Oaks Dorking Rd Tadworth KT20 7NS UK
Harpreet S. Sarna: Pfizer Ltd, Walton Oaks Dorking Rd Tadworth KT20 7NS UK
Pierpaolo Pellicori: British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular & Metabolic Health University of Glasgow Glasgow UK G12 8QQ
Joe Cuthbert: Hull York Medical School Castle Hill Hospital Castle Rd, Cottingham Kingston upon Hull HU16 5JQ UK
John G.F. Cleland: British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular & Metabolic Health University of Glasgow Glasgow UK G12 8QQ
Andrew L. Clark: Hull University Teaching Hospitals Trust, Castle Hill Hospital Castle Rd Cottingham HU16 5JQ UK

Abstract

No abstracts available.

ISSN: 2055-5822 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2055-5822